Anna Turkova

2.3k total citations
47 papers, 649 citations indexed

About

Anna Turkova is a scholar working on Infectious Diseases, Epidemiology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Anna Turkova has authored 47 papers receiving a total of 649 indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Infectious Diseases, 22 papers in Epidemiology and 8 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Anna Turkova's work include HIV/AIDS drug development and treatment (17 papers), HIV/AIDS Research and Interventions (15 papers) and Pneumocystis jirovecii pneumonia detection and treatment (14 papers). Anna Turkova is often cited by papers focused on HIV/AIDS drug development and treatment (17 papers), HIV/AIDS Research and Interventions (15 papers) and Pneumocystis jirovecii pneumonia detection and treatment (14 papers). Anna Turkova collaborates with scholars based in United Kingdom, South Africa and Uganda. Anna Turkova's co-authors include Diana M. Gibb, Claire Thorne, Andrew McArdle, Aubrey J. Cunnington, Elena Chiappini, Luisa Galli, Elisabetta Venturini, Maurizio de Martino, Mary‐Ann Davies and Mike Sharland and has published in prestigious journals such as PLoS ONE, Clinical Infectious Diseases and Journal of Hepatology.

In The Last Decade

Anna Turkova

43 papers receiving 638 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anna Turkova United Kingdom 14 466 301 100 94 80 47 649
Esther C. Casas United Kingdom 15 538 1.2× 437 1.5× 111 1.1× 107 1.1× 54 0.7× 29 679
Cándida Medina Guinea-Bissau 15 459 1.0× 286 1.0× 58 0.6× 240 2.6× 84 1.1× 42 699
Sopheak Thai Belgium 15 633 1.4× 440 1.5× 188 1.9× 168 1.8× 43 0.5× 28 768
Nadia Valin France 17 410 0.9× 409 1.4× 105 1.1× 168 1.8× 35 0.4× 55 791
Arne Kroidl Germany 15 427 0.9× 306 1.0× 110 1.1× 114 1.2× 38 0.5× 43 785
Rolando M. Viani United States 17 704 1.5× 359 1.2× 77 0.8× 214 2.3× 42 0.5× 45 937
Achara Chaovavanich Thailand 12 535 1.1× 379 1.3× 69 0.7× 150 1.6× 26 0.3× 21 703
Cloete van Vuuren South Africa 15 488 1.0× 273 0.9× 91 0.9× 256 2.7× 104 1.3× 29 826
Leslie Serchuck United States 16 508 1.1× 361 1.2× 44 0.4× 213 2.3× 64 0.8× 19 790
Rosie Burton South Africa 18 689 1.5× 593 2.0× 274 2.7× 51 0.5× 66 0.8× 38 979

Countries citing papers authored by Anna Turkova

Since Specialization
Citations

This map shows the geographic impact of Anna Turkova's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Turkova with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Turkova more than expected).

Fields of papers citing papers by Anna Turkova

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Turkova. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Turkova. The network helps show where Anna Turkova may publish in the future.

Co-authorship network of co-authors of Anna Turkova

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Turkova. A scholar is included among the top collaborators of Anna Turkova based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Turkova. Anna Turkova is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mave, Vidya, Mandar Paradkar, Francesca Conradie, et al.. (2025). Tuberculosis disease among people with HIV: therapeutic advances. The Lancet HIV. 12(5). e367–e381.
2.
Bamford, Alasdair, Alfredo Tagarro, Tim R. Cressey, et al.. (2024). Optimising Paediatric HIV Treatment: Recent Developments and Future Directions. Pediatric Drugs. 26(6). 631–648. 3 indexed citations
3.
Bamford, Alasdair, Lisa Hamzah, & Anna Turkova. (2024). Paediatric antiretroviral therapy challenges with emerging integrase resistance. Current Opinion in HIV and AIDS. 19(6). 323–329. 5 indexed citations
4.
Malik, Farihah, Siobhan Crichton, Maria Pokorska‐Śpiewak, et al.. (2024). Effectiveness and Safety of Direct-acting Antivirals for Treatment of Adolescents With HCV/HIV Coinfection: Real-world Data From Europe. The Pediatric Infectious Disease Journal. 43(5). e155–e159. 1 indexed citations
5.
Mackie, Nicola, Alasdair Bamford, Julia Kenny, et al.. (2024). Emerging integrase resistance in an international perinatal virtual clinic. AIDS. 39(3). 276–280. 1 indexed citations
6.
Wasmann, Roeland E., Chishala Chabala, Helena Rabie, et al.. (2023). Evaluating pediatric tuberculosis dosing guidelines: A model-based individual data pooled analysis. PLoS Medicine. 20(11). e1004303–e1004303. 4 indexed citations
7.
Frigati, Lisa, Diana M. Gibb, Joseph I. Harwell, et al.. (2023). The hard part we often forget: providing care to children and adolescents with advanced HIV disease. Journal of the International AIDS Society. 26(3). e26041–e26041. 4 indexed citations
8.
Byott, Matthew, Moira Spyer, Paul R. Grant, et al.. (2023). Sensitive HIV-1 DNA Pol Next-Generation Sequencing for the Characterisation of Archived Antiretroviral Drug Resistance. Viruses. 15(9). 1811–1811. 1 indexed citations
9.
Quartagno, Matteo, Man K. Chan, Anna Turkova, Deborah Ford, & Ian R. White. (2023). The Smooth Away From Expected (SAFE) non-inferiority frontier: theory and implementation with an application to the D3 trial. Trials. 24(1). 556–556.
10.
Turner, Rebecca, Anna Turkova, Alasdair Bamford, et al.. (2022). Borrowing information across patient subgroups in clinical trials, with application to a paediatric trial. BMC Medical Research Methodology. 22(1). 49–49. 5 indexed citations
11.
12.
Chabala, Chishala, Anna Turkova, Anneke C. Hesseling, et al.. (2021). Pharmacokinetics of First-Line Drugs in Children With Tuberculosis, Using World Health Organization–Recommended Weight Band Doses and Formulations. Clinical Infectious Diseases. 74(10). 1767–1775. 17 indexed citations
13.
Rojo, Pablo, Deborah Carpenter, François Venter, Anna Turkova, & Martina Penazzato. (2020). The HIV drug optimization agenda: promoting standards for earlier investigation and approvals of antiretroviral drugs for use in adolescents living with HIV. Journal of the International AIDS Society. 23(S5). e25576–e25576. 6 indexed citations
14.
15.
Turkova, Anna & Alasdair Bamford. (2018). Treating young children co-infected with tuberculosis and HIV. The Lancet HIV. 6(1). e4–e6. 2 indexed citations
16.
Bohlius, Julia, Caroline Foster, Gita Naidu, Mazvita Sengayi, & Anna Turkova. (2018). Cancer in adolescents and young adults living with HIV. Current Opinion in HIV and AIDS. 13(3). 196–203. 11 indexed citations
17.
Judd, Ali, Katja Doerholt, Carlo Giaquinto, et al.. (2016). Long - term trends in mortality and AIDS-defining events among perinatally HIV-infected children across Europe and Thailand. St George's Online Research Archive (St George's University of London). 1 indexed citations
18.
Davies, Mary‐Ann, Diana M. Gibb, & Anna Turkova. (2016). Survival of HIV-1 vertically infected children. Current Opinion in HIV and AIDS. 11(5). 455–464. 46 indexed citations
19.
Crook, Angela M., Anna Turkova, Victor Musiime, et al.. (2016). Tuberculosis incidence is high in HIV-infected African children but is reduced by co-trimoxazole and time on antiretroviral therapy. BMC Medicine. 14(1). 50–50. 34 indexed citations
20.
Turkova, Anna, Ali Judd, Ruth Goodall, et al.. (2015). Prevalence, incidence, and associated risk factors of tuberculosis in children with HIV living in the UK and Ireland (CHIPS): a cohort study. The Lancet HIV. 2(12). e530–e539. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Esther C. Casas Breakdown of academic impact, for papers by Cándida Medina Breakdown of academic impact, for papers by Sopheak Thai Breakdown of academic impact, for papers by Nadia Valin Breakdown of academic impact, for papers by Arne Kroidl Breakdown of academic impact, for papers by Rolando M. Viani Breakdown of academic impact, for papers by Achara Chaovavanich Breakdown of academic impact, for papers by Cloete van Vuuren Breakdown of academic impact, for papers by Leslie Serchuck Breakdown of academic impact, for papers by Rosie Burton
Rankless by CCL
2026